About the Product

Description


Predplit 30 Tablet contains Prednisolone 30 mg, a corticosteroid medicine widely used for the management of inflammatory, allergic, autoimmune, and immune-mediated disorders. It helps in reducing inflammation, suppressing excessive immune responses, and relieving symptoms associated with a variety of acute and chronic medical conditions. The medicine plays an important role in controlling disease activity and improving patient comfort when prescribed under appropriate medical supervision.

Prednisolone works by modifying the body's inflammatory and immune responses. It helps reduce redness, swelling, itching, pain, and tissue damage caused by inflammation or overactive immune system activity. Due to its broad therapeutic applications, it is frequently prescribed in conditions involving the respiratory system, skin, joints, blood disorders, endocrine disorders, and various autoimmune diseases. Its effectiveness has made it one of the most widely utilized corticosteroids in clinical practice.

The tablet is commonly used in the treatment of allergic reactions, asthma exacerbations, rheumatoid arthritis, lupus, inflammatory bowel disease, dermatological disorders, nephrotic syndrome, and several other inflammatory conditions. Depending on the medical condition being treated, Prednisolone may be used for short-term symptom control or as part of a long-term disease management strategy. Proper dosing and gradual dose adjustment are important aspects of therapy to ensure optimal outcomes.

With the increasing need for effective anti-inflammatory and immunomodulatory therapies, Predplit 30 Tablet maintains strong demand across multiple therapeutic specialties. Its established clinical utility, broad prescribing base, and extensive range of indications make it a valuable product for retailers and distributors. The product offers significant business potential and contributes to sustained growth opportunities within the pharmaceutical market.

Predplit 30 Tablet may cause increased appetite, weight gain, indigestion, mood changes, insomnia, headache, fluid retention, elevated blood sugar levels, or increased susceptibility to infections. Long-term use may be associated with osteoporosis, adrenal suppression, hypertension, cataracts, or other corticosteroid-related adverse effects.

Predplit 30 Tablet is indicated for allergic disorders, asthma, rheumatoid arthritis, lupus, inflammatory bowel disease, skin disorders, autoimmune diseases, nephrotic syndrome, blood disorders, endocrine disorders, and other inflammatory or immune-mediated conditions. It helps reduce inflammation, control immune responses, and alleviate associated symptoms.

This medication should be used only under the supervision of a qualified healthcare professional. The prescribed dosage should be followed carefully, and treatment should not be stopped abruptly without medical advice. Patients with diabetes, hypertension, osteoporosis, infections, liver disease, kidney disease, or gastrointestinal disorders should inform their physician before use. Long-term therapy may require periodic medical monitoring.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children. Do not use after the expiry date or if the packaging is damaged, opened, or shows signs of tampering.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions